{"disease":{"id":"gram-negative-bacteremia","name":"gram negative bacteremia"},"drugs":{"marketed":[{"drug_id":"aztreonam","indication_name":"Aerobic Gram-Negative Bacteremia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Azactam","generic_name":"AZTREONAM","company_name":"Bristol-Myers Squibb","drug_phase":"marketed","molecular_target":"","drug_class":"Monobactam Antibacterial [EPC]","quality_score":10,"revenue":null,"mechanism":"Aztreonam inhibits bacterial cell wall synthesis, acting as a bactericidal agent."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06080698","title":"Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":1030,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT06174649","title":"Fast Antibiotic Susceptibility Testing for Gram Negative Bacteremia Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":900,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT03218397","title":"Rapid Identification and Phenotypic Susceptibility Testing for Gram-Negative Bacteremia","phase":"NA","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"Duke University","has_results":true},{"nct_id":"NCT07491419","title":"The Impact of Fast Antimicrobial Sensitivity Testing Tools on Stewardship Antibiotic and Clinical Outcome (ACT-FAST)","phase":"NA","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Istituto Clinico Humanitas","has_results":false},{"nct_id":"NCT04291768","title":"Shortened Antibiotic Treatment of 5 Days in Gram-negative Bacteremia","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":380,"lead_sponsor_name":"Thomas Benfield","has_results":false},{"nct_id":"NCT06135350","title":"Clinical Trial to Study the Efficacy and Safety of Fluorothiazinone (N.F. Gamaleya NRCEM) in Prophylaxis of Nosocomial Bacterial Infections With Participation of Patients on MV","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":234,"lead_sponsor_name":"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation","has_results":false},{"nct_id":"NCT05893147","title":"BALANCE+ Vanguard Phase","phase":"NA","overall_status":"COMPLETED","enrollment_count":174,"lead_sponsor_name":"Sunnybrook Health Sciences Centre","has_results":false},{"nct_id":"NCT05210387","title":"Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections","phase":"NA","overall_status":"TERMINATED","enrollment_count":107,"lead_sponsor_name":"Hospital Moinhos de Vento","has_results":false},{"nct_id":"NCT05605275","title":"CRP and PCT as Predictors of Sepsis Cause","phase":"","overall_status":"COMPLETED","enrollment_count":81,"lead_sponsor_name":"Osijek University Hospital","has_results":false},{"nct_id":"NCT03745014","title":"Clinical Impact of Fast Phenotypic Antimicrobial Susceptibility Testing on Patients With Gram-Negative Rod Bacteremia","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Accelerate Diagnostics, Inc.","has_results":false}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}